Hamza Igamane fee agreed as medical timeline emerges ahead of Rangers departure
Hamza Igamane has been at the centre of Rangers’ transfer business all summer.
After an excellent first season at Ibrox, the attacker has been continuously linked away throughout the transfer window.
After Russell Martin confirmed that Igamane refused to come on against St. Mirren, an exit looked likely in the final days of the window.
Now, reports on Tuesday suggest that Rangers had agreed a £10.5million fee for Igamane with Lille.
Hamza Igamane to travel to Lille on Thursday for medical
Despite the attacker claiming that he was injured for the St. Mirren match, Martin confirmed that Igamane should pass a medical ahead of a Rangers departure.
Now, after a fee has been settled, Fabrice Hawkins has confirmed via X on 26 August that an agreement in principle has been reached.
- Igamane only signed for Rangers last season AS Far
- The attacker quicky established himself as one of the best players at Ibrox
- Rangers are now set to make a hefty profit on the winger
Igamane is expected to fly out to France on Thursday to undergo his medical for Lille.
If all goes well, the attacker is expected to sign a three-year deal with the Ligue 1 side, with an option of an additional year.
Hamza Igamane has been a highly successful signing at Rangers
Despite the sour end to his time at Rangers, the Ibrox faithful cannot deny the success of the signing.
Igamane rightly earned plaudits at Rangers last season for his 16 goals in all competitions.
Now, the Gers are set to make a 500% profit in just a year on the attacker, showing a sizable profit.
Despite the faults of the squad at the moment, the 49ers deserve credit for demanding such a high fee for the winger, who has done little to impress under Martin.
Hopefully. These funds can then be reinvested in the squad within the remaining days of the transfer window.
Sign up for the Ibrox News WhatsApp channel and turn on notifications to have all the latest, breaking Rangers news sent straight to your phone.